ArticleBiomedicines2023

Combined Inhibition of Indolamine-2,3-Dioxygenase 1 and C-X-C Chemokine Receptor Type 2 Exerts Antitumor Effects in a Preclinical Model of Cervical Cancer.

Solangy Lizcano-Meneses et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.